C12Y 204/01092
-galactosylglucosylceramide n-acetylgalactosaminyltransferase
Official title: (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase (2.4.1.92)
C12Y204/01092 (-galactosylglucosylceramide n-acetylgalactosaminyltransferase) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 3
- Inventors
- 16
- Latest grant
- 30 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase30 Jul 2024US 12,049,656 B2Synaffix B.V.
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase12 Apr 2022US 11,299,759 B2Synaffix B.V.
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferase5 Jun 2018US 9,988,661 B2Synaffix B.V.
- Glycosyltransferase engineering for chemoenzymatic total synthesis of gangliosides3 Sep 2026US 2026/0258378 A1The Regents of the University of California
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a ß(1,4)-n-acetylgalactosaminyltransferase30 Mar 2023US 2023/0100074 A1Synaffix B.V.
- Transgenic cloned pig for xenotransplantation expressing human cd46 and tbm genes, in which porcine endogenous retrovirus envelope c is negative and ggta1, cmah, igb3s and ß4galnt2 genes are knocked out, and method for preparing same11 Aug 2022US 2022/0248647 A1Optipharm Co., Ltd
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a ß(1,4)-n-acetylgalactosaminyltransferase30 Aug 2018US 2018/0245119 A1Synaffix B.V.
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a ß(1,4)-n-acetylgalactosaminyltransferase11 May 2017US 2017/0130256 A1Synaffix B.V.
Most cited
By later US patents
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferase4US 9,988,661 B2Synaffix B.V. · 2018
- Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase1US 11,299,759 B2Synaffix B.V. · 2022